INmune Bio Inc
NASDAQ:INMB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
INmune Bio Inc
NASDAQ:INMB
|
US |
|
Pultegroup Inc
NYSE:PHM
|
US |
|
SandRidge Energy Inc
NYSE:SD
|
US |
|
S
|
Star7 SpA
MIL:STAR7
|
IT |
|
Ci&T Inc
NYSE:CINT
|
BR |
|
Stride Inc
NYSE:LRN
|
US |
|
M
|
Motus Holdings Ltd
JSE:MTH
|
ZA |
|
Apollo Global Management Inc
NYSE:APO
|
US |
|
Ferrari NV
MIL:RACE
|
IT |
|
AerSale Corp
NASDAQ:ASLE
|
US |
|
Levi Strauss & Co
NYSE:LEVI
|
US |
|
F
|
Fluidigm Corp
F:FLB
|
US |
|
Canadian Pacific Railway Ltd
TSX:CP
|
CA |
|
Stellantis NV
MIL:STLAM
|
NL |
|
Roku Inc
NASDAQ:ROKU
|
US |
|
Molson Coors Beverage Co
NYSE:TAP
|
US |
|
Chunghwa Telecom Co Ltd
TWSE:2412
|
TW |
|
Brambles Ltd
ASX:BXB
|
AU |
|
P
|
Phillips Edison & Co Inc
NASDAQ:PECO
|
US |
|
Alexandria Real Estate Equities Inc
NYSE:ARE
|
US |
|
Restaurant Brands International Inc
NYSE:QSR
|
CA |
|
Pinelawn Cemetery
OTC:PLWN
|
US |
|
Geberit AG
SIX:GEBN
|
CH |
|
S
|
Seagate Technology Holdings PLC
XBER:847
|
SG |
Wall St Price Targets
INMB Price Targets Summary
INmune Bio Inc
According to Wall Street analysts, the average 1-year price target for
INMB is 7.14 USD with a low forecast of 4.04 USD and a high forecast of 9.45 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is INMB's stock price target?
Price Target
7.14
USD
According to Wall Street analysts, the average 1-year price target for
INMB is 7.14 USD with a low forecast of 4.04 USD and a high forecast of 9.45 USD.
What is the Revenue forecast for INmune Bio Inc?
Projected CAGR
206%
The compound annual growth rate for Revenue over the next 8 years is 206%.